Squro

Squro

quetiapine

Manufacturer:

Intas Pharmaceuticals

Distributor:

Alliance Pharma
Concise Prescribing Info
Contents
Quetiapine fumarate
Indications/Uses
Schizophrenia. Acute monotherapy or adjunct therapy of bipolar mania, depressive episodes associated w/ bipolar disorder. Major depressive disorder.
Dosage/Direction for Use
Schizophrenia Initially 300 mg/day, may be titrated w/in a dose range of 400-800 mg/day. Bipolar disorder: Acute monotherapy or adjunct therapy of bipolar mania 300 mg once daily in the evening on day 1, & 600 mg on day 2. May be adjusted to 400 & 800 mg starting on day 3. Depressive episodes associated w/ bipolar disorder Administer once daily in the evening to reach 300 mg/day on day 4. Major depressive disorder: Adjunct therapy w/ antidepressants Initially 50 mg once daily in the evening. May be increased to 150 mg once daily in the evening on day 3. Recommended dose: 150-300 mg/day.
Administration
Should be taken on an empty stomach.
Special Precautions
CV & cerebrovascular disease, hypotension, extrapyramidal symptoms, tardive dyskinesia, neuroleptic malignant syndrome, neutropenia, hyperglycemia, QT prolongation.
Adverse Reactions
Dry mouth, sedation, somnolence, increased appetite, headache, constipation, nausea, wt gain, dyspepsia & fatigue.
MIMS Class
ATC Classification
N05AH04 - quetiapine ; Belongs to the class of diazepines, oxazepines and thiazepines antipsychotics.
Presentation/Packing
Form
Squro SR tab 200 mg
Packing/Price
60's
Form
Squro SR tab 50 mg
Packing/Price
60's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in